Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to antiviral treatment  in B-cell lymphoma patients.
Patients with hematologic diseases have experienced COVID-19 with prolonged, progressive course. Then, we present clinical, pathological, and virologic genetic analyses of three cases of prolonged COVID-19 among patients undergoing treatment for B-cell lymphoma.